Skip to content

Clinical trials

Alzheimer Disease trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Mexico Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20073
20084
20093
20101
20132
20141
20152
20162
20171
20183
20202
20215
20222
20231
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated18
Completed15
Recruiting7
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche7
GlaxoSmithKline5
Washington University School of Medicine4
Pfizer3
Bristol-Myers Squibb2
FORUM Pharmaceuticals Inc2
Novartis Pharmaceuticals2
AstraZeneca1
Biogen1
Carnot Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease42
Dementia9
Brain Diseases4
Nervous System Diseases3
Neurodegenerative Diseases3
Tauopathies3
Central Nervous System Diseases2
Mental Disorders2
Neurocognitive Disorders2
Parkinson Disease2

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.